| 000 | 01741 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518055119.0 | ||
| 264 | 0 | _c20200316 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1751-2980 | ||
| 024 | 7 |
_a10.1111/1751-2980.12816 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Ji Yao | |
| 245 | 0 | 0 |
_aLactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. _h[electronic resource] |
| 260 |
_bJournal of digestive diseases _cOct 2019 |
||
| 300 |
_a547-556 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGastrointestinal Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aGastrointestinal Microbiome _xdrug effects |
| 650 | 0 | 4 |
_aHepatic Encephalopathy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLactulose _xtherapeutic use |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBajaj, Jasmohan S | |
| 700 | 1 | _aWang, Jiang Bin | |
| 700 | 1 | _aShang, Jia | |
| 700 | 1 | _aZhou, Xin Min | |
| 700 | 1 | _aGuo, Xiao Lin | |
| 700 | 1 | _aZhu, Xuan | |
| 700 | 1 | _aMeng, Li Na | |
| 700 | 1 | _aJiang, Hai Xing | |
| 700 | 1 | _aMi, Yu Qiang | |
| 700 | 1 | _aXu, Jian Ming | |
| 700 | 1 | _aYang, Jin Hui | |
| 700 | 1 | _aWang, Bai Song | |
| 700 | 1 | _aZhang, Ning Ping | |
| 773 | 0 |
_tJournal of digestive diseases _gvol. 20 _gno. 10 _gp. 547-556 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/1751-2980.12816 _zAvailable from publisher's website |
| 999 |
_c30040721 _d30040721 |
||